The United Nations’ International Narcotics Control Board (INCB) tells us that in 2016, the United Kingdom was the largest exporter of cannabis in the world. Canada might have ramped up production since then but the country only produced a second-place snagging 80.7 tons that year, compared to the 95 tons produced by the UK—a whopping 44.9% of the world’s total marijuana production.
We don’t hear about UK weed because almost all of the UK’s cannabis production and exports are for a cannabis-derived prescription medicine from GW Pharmaceuticals, called Sativex, which uses a mix of THC and CBD to treat muscle stiffness and spasms from multiple sclerosis. Since the British government doesn’t classify Sativex as a cannabis product, it doesn’t ban it as it does virtually every other form of the plant and its parts.
But oddly enough, to the British government, marijuana has no medical value.
Smith commends Washington state’s Liquor and Cannabis Board, whom he met with on a recent trip, for upholding “strict age limits and health warnings on all packaging” that allowed the state to collect $1B in tax revenues without an increase in use among youth and other fictional side effects used to scare lawmakers off of legalization.
Davie is a long time cannabis professional who has worked not only as a cultivator but in all aspects of retail cannabis. From budtender, to wholesale and retail management, and from harvester to advanced hydroponic specialist, Davie has been around the block more than once. Now residing in beautiful British Columbia, Davie now works with acres of greenhouses, producing some of the best buds in the country.